| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Veracyte, Inc. (VCYT) have been net sellers, shedding 168,763 shares worth roughly $8.4M on balance.
VCYT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 578.5K | $27.32M | - | |
| CFO | 173.3K | $8.18M | - | |
| Other | 149.8K | $7.07M | - | |
| VP | 137.2K | $6.48M | - | |
| Other | 132.3K | $6.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Leite John49 | Chief Commercial Officer-clia | Sell | 1,278 | $47.51 | $60,717.78 | -1.5% | -23.5% | - | |
| Nov 25, 2025 | Leite John49 | Chief Commercial Officer-clia | Sell | 2,808 | $50.00 | $140,400.00 | -3.2% | -27.6% | - | |
| Nov 25, 2025 | Jones Evan/ Fa70 | Director | Sell | 1,106 | $50.25 | $55,575.73 | -3.6% | -27.6% | - | |
| Nov 20, 2025 | Holstein Jens | Director | Sell | 10,000 | $42.36 | $423,563.05 | -9.8% | -10.4% | - | |
| Nov 10, 2025 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 10,920 | $41.20 | $449,907.35 | -11.7% | -13.3% | - | |
| Nov 5, 2025 | Eastham Karin65 | Director | Sell | 9,674 | $40.02 | $387,191.21 | -41.6% | -18.0% | - | |
| Nov 5, 2025 | Chambers Rebecca73 | Chief Financial Officer | Sell | 7,000 | $41.00 | $287,000.00 | -5.3% | -18.0% | - | |
| Nov 5, 2025 | McGuire Annie46 | SVP, General Counsel | Sell | 6,466 | $40.00 | $258,640.00 | -7.2% | -18.0% | - | |
| Nov 5, 2025 | Jones Evan/ Fa70 | Director | Sale+OE | 43,196 | $45.06 | $1,946,287.73 | -11.8% | -18.0% | - | |
| Oct 6, 2025 | Febbo Phillip G.63 | Chief Scientific &Med Officer | Sell | 8,349 | $36.02 | $300,709.27 | -8.3% | +21.1% | - |